Adverse events in mavacamten treatment for hypertrophic cardiomyopathy: a study based on the US FDA Adverse Event Reporting System database

Yan Yilong, Zhang Yi'nan, Zhao Zhigang

PDF(406 KB)
PDF(406 KB)
Adverse Drug Reactions Journal ›› 2025, Vol. 27 ›› Issue (4) : 207-211. DOI: 10.3760/cma.j.cn114015-20240620-00473

Adverse events in mavacamten treatment for hypertrophic cardiomyopathy: a study based on the US FDA Adverse Event Reporting System database

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 27(4): 207-211 https://doi.org/10.3760/cma.j.cn114015-20240620-00473

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(406 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉